Application of tobramycin benzyl ether as an antibiotic adjuvant capable of sensitizing multidrug-resistant Gram-negative bacteria to rifampicin
RSC Medicinal Chemistry · 2024 · 15 (3) · 1055-1065
DOI: 10.1039/d3md00602f ↗Kurz gefasst
Fachartikel in der Zeitschrift RSC Medicinal Chemistry, 2024. Verfasst von Danzel Marie Ramirez und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, University of Manitoba Winnipeg MB R3T 2N2 Canada frank.schweizer@cc.umanitoba.ca. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
The emergence of aminoglycoside resistance has prompted the development of amphiphilic aminoglycoside derivatives which target bacterial membranes.
Autor:innen und Institutionen
- Department of Chemistry, University of Manitoba Winnipeg MB R3T 2N2 Canada frank.schweizer@cc.umanitoba.ca.
- Department of Microbiology, University of Manitoba Winnipeg MB R3T 2N2 Canada.
ORCID-Profile: Frank Schweizer
Förderung
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Ramirez, D. M., Dhiman, S., Mukherjee, A., Wimalasekara, R., & Schweizer, F. (2024). Application of tobramycin benzyl ether as an antibiotic adjuvant capable of sensitizing multidrug-resistant Gram-negative bacteria to rifampicin. RSC Medicinal Chemistry, 15(3), 1055-1065. https://doi.org/10.1039/d3md00602f
Vancouver
Ramirez DM, Dhiman S, Mukherjee A, Wimalasekara R, Schweizer F. Application of tobramycin benzyl ether as an antibiotic adjuvant capable of sensitizing multidrug-resistant Gram-negative bacteria to rifampicin. RSC Medicinal Chemistry. 2024;15(3):1055-1065. doi:10.1039/d3md00602f
BibTeX
@article{Ramirez2024,
author = {Ramirez, Danzel Marie and Dhiman, Shiv and Mukherjee, Ayan and Wimalasekara, Ruwani and Schweizer, Frank},
title = {Application of tobramycin benzyl ether as an antibiotic adjuvant capable of sensitizing multidrug-resistant Gram-negative bacteria to rifampicin},
journal = {RSC Medicinal Chemistry},
year = {2024},
volume = {15},
number = {3},
pages = {1055--1065},
doi = {10.1039/d3md00602f}
}
EUVIMED